This study is in progress, not accepting new patients
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease
Summary
- Eligibility
- for people ages 18-65 (full criteria)
- Location
- at UC Irvine UCLA UCSF
- Dates
- study startedcompletion around
- Principal Investigator
- by Jenny S. Sauk, MD (ucla)

Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at University of California Health
- Jenny S. Sauk, MD (ucla)
HS Associate Clinical Professor, Medicine. Authored (or co-authored) 64 research publications
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Janssen Research & Development, LLC
- ID
- NCT05242471
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- About 703 people participating
- Last Updated